May 31, 2016 Cellectar Biosciences Announces USPTO Issues Patent for its Radiotherapeutic PDC Portfolio, Further Strengthening and Expanding Protection for Its Delivery Platform Learn More
May 25, 2016 Cellectar Biosciences Announces USPTO Issues Patent for New Phospholipid Drug Conjugate (PDC) with Paclitaxel Learn More
May 24, 2016 Cellectar Biosciences to Present at the 5th Annual SeeThru Equity Microcap Investor Conference Learn More